Total Payments
$224,225
2024 Payments
$1,025
Companies
41
Transactions
562
Medicare Patients
10,982
Medicare Billing
$1.4M
Payment Breakdown by Category
Other$157,011 (70.0%)
Travel$41,764 (18.6%)
Food & Beverage$20,725 (9.2%)
Consulting$4,700 (2.1%)
Education$25.86 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $139,011 | 67 | 62.0% |
| Travel and Lodging | $41,764 | 94 | 18.6% |
| Food and Beverage | $20,725 | 387 | 9.2% |
| Honoraria | $18,000 | 9 | 8.0% |
| Consulting Fee | $4,700 | 2 | 2.1% |
| Education | $25.86 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $110,874 | 139 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, INC. | $28,662 | 42 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $21,968 | 35 | $0 (2018) |
| Medtronic Vascular, Inc. | $15,686 | 68 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $12,672 | 34 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $7,469 | 36 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $5,661 | 31 | $0 (2024) |
| Abbott Laboratories | $5,654 | 36 | $0 (2024) |
| Amgen Inc. | $5,587 | 14 | $0 (2024) |
| Boston Scientific Corporation | $4,218 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,025 | 33 | AstraZeneca Pharmaceuticals LP ($212.00) |
| 2023 | $1,781 | 45 | Janssen Pharmaceuticals, Inc ($381.82) |
| 2022 | $1,247 | 7 | Janssen Pharmaceuticals, Inc ($1,019) |
| 2021 | $8,765 | 31 | AstraZeneca Pharmaceuticals LP ($5,307) |
| 2020 | $19,687 | 43 | Janssen Pharmaceuticals, Inc ($9,208) |
| 2019 | $102,254 | 188 | Janssen Pharmaceuticals, Inc ($60,737) |
| 2018 | $45,179 | 101 | Janssen Pharmaceuticals, Inc ($22,240) |
| 2017 | $44,288 | 114 | Janssen Pharmaceuticals, Inc ($14,670) |
All Payment Transactions
562 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $37.51 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Cardiology | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Genetic Disease | ||||||
| 12/10/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $93.35 | General |
| Category: Heart Failure | ||||||
| 11/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Cardiology | ||||||
| 11/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Cardiology | ||||||
| 11/15/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Siemens Medical Solutions USA, Inc. | ARTIS icono biplane (Device) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: AT - Fixed interventional x-ray/angiography fluoroscopy | ||||||
| 10/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $40.30 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/06/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $41.15 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/30/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $14.21 | General |
| Category: Cardiology | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $14.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/19/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $115.71 | General |
| Category: EMBLEM_CRM | ||||||
| 07/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.29 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/24/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $34.62 | General |
| Category: Cardiovascular | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $21.75 | General |
| Category: Coronary | ||||||
| 05/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 3,459 | 5,408 | $1.4M | $428,095 |
| 2022 | 23 | 2,943 | 4,506 | $2.1M | $425,503 |
| 2021 | 24 | 2,698 | 3,889 | $1.7M | $348,253 |
| 2020 | 26 | 1,882 | 2,918 | $1.1M | $217,666 |
Total Patients
10,982
Total Services
16,721
Medicare Billing
$1.4M
Procedure Codes
109
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 572 | 986 | $400,316 | $156,668 | 39.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 285 | 296 | $272,024 | $57,898 | 21.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 151 | 366 | $127,002 | $38,402 | 30.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 88 | 499 | $68,862 | $33,526 | 48.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 136 | 138 | $80,730 | $20,591 | 25.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 281 | 282 | $65,142 | $16,718 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 163 | $49,715 | $16,519 | 33.2% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 67 | 68 | $60,996 | $16,089 | 26.4% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 80 | 456 | $37,848 | $9,847 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $21,206 | $5,996 | 28.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $18,777 | $5,603 | 29.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 25 | 25 | $20,125 | $4,965 | 24.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 90 | 210 | $29,411 | $4,920 | 16.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 597 | 730 | $18,980 | $4,773 | 25.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 62 | $13,764 | $4,349 | 31.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 74 | 164 | $22,631 | $4,180 | 18.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 272 | 319 | $33,814 | $4,127 | 12.2% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 50 | 64 | $10,814 | $3,664 | 33.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 13 | 13 | $12,649 | $3,304 | 26.1% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 32 | 40 | $8,160 | $3,117 | 38.2% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 78 | 78 | $12,714 | $1,793 | 14.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 27 | 27 | $11,880 | $1,636 | 13.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 82 | 83 | $5,810 | $1,568 | 27.0% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2023 | 15 | 22 | $5,487 | $1,492 | 27.2% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 17 | 46 | $11,362 | $1,405 | 12.4% |
About Dr. Neal White, MD
Dr. Neal White, MD is a Internal Medicine healthcare provider based in Walnut Creek, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659301216.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Neal White, MD has received a total of $224,225 in payments from pharmaceutical and medical device companies, with $1,025 received in 2024. These payments were reported across 562 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($139,011).
As a Medicare-enrolled provider, White has provided services to 10,982 Medicare beneficiaries, totaling 16,721 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Interventional Cardiology, Cardiovascular Disease
- Location Walnut Creek, CA
- Active Since 07/03/2006
- Last Updated 11/11/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659301216
Products in Payments
- XARELTO (Drug) $111,100
- ANDEXXA (Biological) $24,792
- SAMSCA (Drug) $21,968
- FARXIGA (Drug) $12,255
- LifeVest (Device) $7,469
- Resolute (Device) $6,368
- ENTRESTO (Drug) $5,474
- Corlanor (Drug) $5,230
- CoreValve Evolut (Device) $3,918
- ANDEXXA (Drug) $3,745
- WATCHMAN (Device) $2,245
- AMPLATZER Vascular Plugs (Device) $1,774
- CardioMEMS HF System (Device) $1,653
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,368
- Occluders (Device) $1,360
- GENERAL THERAPIES (Device) $947.76
- 3F (Device) $804.10
- Azure (Device) $554.13
- HeartMate II LVAS (Device) $513.83
- Impella (Device) $376.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Walnut Creek
Anthony Padula, M.d, M.D
Internal Medicine — Payments: $804,141
Internal Medicine $804,141
Dr. Richard Chang, M.d, M.D
Internal Medicine — Payments: $295,804
Internal Medicine $295,804
Dr. Aditi Choudhry, M.d, M.D
Internal Medicine — Payments: $69,819
Internal Medicine $69,819
Dr. Andrew Dublin, Md, MD
Internal Medicine — Payments: $65,190
Internal Medicine $65,190
Dr. Bhavna Malik, Md, MD
Internal Medicine — Payments: $39,855
Internal Medicine $39,855
Dr. Helen Stacey, Md, MD
Internal Medicine — Payments: $39,394
Internal Medicine $39,394